Efficacy of clindamycin in preventing infection and failure after dental implant placement: a placebo-controlled randomized clinical trial. - Efficacy of Clindamycin preventing dental implant failure and infection

Iciar Arteagoitia Calvo0 个研究点目标入组 62 人开始时间: 2018年9月17日最近更新: 2019年2月28日

适应症

试验速览

暂无简介。

•Healthy subjects over the age of 18, without discrimination on the basis of sex or race, who will be given a single implant and who, once informed, will sign a consent form to participate in the trial.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 50
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 12

•Pre-randomisation exclusion criteria: patients allergic to amoxicillin, patients who had taken antibiotics for any reason during the 15 days prior to surgery, patients with decompensated systemic pathologies: cardiac, respiratory, endocrine, metabolic, hepatic, haematological, risk of bacterial endocarditis, immunosuppressed, with valvular and orthopedic prostheses in treatment with bisphosphonates, anticoagulants and platelet antiaggregants and those with allergy to any of the drugs used in the trial. Irradiated patients in the cervical-maxillofacial territory. Pregnant women, women suspected of being pregnant or breastfeeding. Patients with a history of antibiotic-associated colitis.
•Post-randomisation exclusion criteria. At the request of the patient with abandonment of the trial or loss of follow-up.

发起方

Iciar Arteagoitia Calvo